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Materials and Methods 
 
Mouse embryonic stem cell (mESC) culture 
Mouse embryonic stem cells (mESCs) (R1 ES cells) were cultured in serum-free 2i 
media (1:1 of DMEM/F-12 and Neurobasal media, supplemented with 1x N-2 
supplement, 1x B-27 supplement, 100 U/ml PenStrep, 3 μg/ml AlbuMAX™ II, 1x MEM 
NEAA, 1mM Sodium pyruvate, 1mM L-glutamine (all from Thermo Fisher Scientific), 
0.1 μM 2-Mercaptoethanol (Sigma-Aldrich), 1mM MEK inhibitor (PD0325910, 
Stemgent), 3mM GSK3β inhibitor (CHIR99021, Stemgent) and 100 U/ml LIF (Leukemia 
Inhibitory Factor, EMD Millipore) without feeder cells). Prior to cell culturing, all the 
flasks or petri dishes were incubated in 37°C for more than 5 hours with 5 μg/ml poly-L-
ornithine (PLO, Sigma) in 1x PBS buffer, followed by 5 μg/ml Laminin (VWR) in 1x 
PBS buffer with >5 hours incubation in 37°C. The cells were grown in a 37°C incubator 
maintaining 5% CO2 in a water-saturated atmosphere. Cell culture media were 
exchanged every 24 hours. Pluripotency of mESC was checked periodically by alkaline 
phosphatase (AP) expression level using Alkaline Phosphatase Live Stain Kit (Thermo 
Fisher Scientific), and by cell phenotype. Note that stem cell-specific large/stable Pol II 
and Mediator clusters may also serve as stemness markers.    
 
Homology-directed repair (HDR) DNA template design 
Plasmids containing Dendra2-Rpb1 and Dendra2-Med19 DNA repair templates were 
synthesized with long homology arms (~500 bp) by GeneArt® Gene Synthesis (Life 
Technologies, Carlsbad, CA). Silent mutations were included in the repair template 
design to mask the sgRNA target sites and avoid Cas9 degradation of the repair 
templates. Repair templates were linearized by PCR using primers listed in Table S2. 
Left homology arm (LHA) and right homology arm (RHA) sequences were designed 
from the mouse Rpb1 gene (ENSMUSG00000005198) covering distances of 427 bp and 
314 bp respectively from each side of the ATG start codon of Rpb1. The Dendra2 (31) 
sequence (690 bp) was inserted between these homology arms to fuse Dendra2 with the 
N-terminus of the Rpb1 protein. The same strategy was applied to target the mouse 
Med19 gene (ENSMUSG00000027080) with 301 bp LHA and 207 bp RHA sequences 
flanking Dendra2, which lies in-frame with the ATG start codon of Med19.   
   To generate a Halo-Med19 repair template, HaloTag was inserted in place of 
Dendra2 in the Dendra2-Med19 plasmid using the Gibson Assembly® Ultra Kit from 
SGI-DNA. Prior to assembly, the Dendra2-Med19 plasmid was linearized by PCR to 
form a vector omitting the Dendra2 sequence and with ~20 bp overhangs for HaloTag 
insertion. The HaloTag insert was amplified by PCR from pENTR4-HaloTag (w876-1) 
using primers that provide a 40 bp overlap with each end of the destination vector. 
Gibson primers are listed in Table S3.  
   To replace Dendra2 in the Dendra2-Rpb1 repair template and create the Halo-
Rpb1 repair template we used AarI (Thermo Fisher) and PCR to create sequence-
independent sticky ends between the HaloTag insert and the Rpb1 backbone. Table S4 
lists PCR primers used to generate compatible fragments from pENTR4-HaloTag and 
Dendra2-Rpb1 repair template. AarI digestion of the two PCR products, and ligation with 
T7 Ligase (NEB), produced the Halo-Rpb1 repair template plasmid. pENTR4-HaloTag 
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(w876-1) was a gift from Eric Campeau (Addgene plasmid # 29644). AarI and BbsI were 
obtained from Thermo Fisher. All other restriction enzymes were obtained from NEB. 
 
CRISPR/Cas9 engineering for endogenous Pol II and Mediator labeling  
Single-guide RNAs (sgRNAs) targeting +/- 100 bps from the start codons of the 
Rbp1 and Med19 genes were designed using the web-based CRISPR Design tool 
(http://crispr.mit.edu). Three sgRNAs were selected for each target (Table S1). DNA 
oligonucleotides for sgRNAs with BbsI restriction sites were obtained from Integrated 
DNA Technologies (IDT). Streptococcus pyogenes Cas9 vectors (pSpCas9(BB)-2A-Puro 
(PX459) V2.0, Addgene #62988) and DNA oligonucleotides were digested using BbsI 
enzyme (Thermo Fisher) and ligated to form sgRNA-Cas9 plasmids. These plasmids 
were transformed into Stbl3 competent cells (Life Technologies) and sequence-verified. 
pSpCas9 (BB)-2A-Puro (PX459) V2.0 was a gift from Feng Zhang (Addgene plasmid 
#62988).   
   700 ng sgRNA-Cas9 plasmids and 2 μg repair template DNA were electroporated 
to 1-2 million cells using 4D Nucleofector X Unit (Lonza) with P3 Primary Cell 
Nucleofection Kit (Lonza). Cells were plated to 6-well plates in recovery buffer (2i, 
supplemented with 2-5% FBS). After 2 hour incubation, recovery buffer was replaced by 
2i media. Note that among three sgRNAs for each gene, sgRNA #2 for Rpb1 and sgRNA 
#1 for Med19 were most successful for CRISPR/Cas9 gene editing.  
In a first step we generated monoclonal cell lines expressing either Dendra2-Rpb1 or 
Dendra2-Med19. In a second step, we added the orthogonal label to generate monoclonal 
Dendra2-Rpb1/Halo-Med19 and Dendra2-Med19/Halo-Rpb1 cell lines. 
 
Flow cytometric cell sorting using fluorescence-activated cell sorting (FACS) 
Within 48-72 hours after co-transfection with sgRNA-Cas9 plasmids and repair 
templates, the cells were tested on the microscope stage to confirm successful 
CRISPR/Cas9 gene editing. For Dendra2-fused cells 488-nm illumination was used, and 
for Halo-fused cells 642-nm illumination was used after 20 min incubation with 100nM 
JF646-Halotag ligand (13). Fluorescence signal from the nucleus in a small fraction of 
cells confirmed successful gene editing. To create monoclonal cell lines, fluorescence-
activated cell sorting (FACS) was utilized. For FACS preparation, the cells were 
centrifuged to discard 2i media, resuspended in FACS buffer (25mM HEPES (pH7.4), 
1mM EDTA, 1% FBS in 1x PBS buffer), then strained through a 35 μm sieve (Falcon, 
#2235).  
   Cells were sorted using BD FACS Aria I at the Koch Institute Flow Cytometry 
Core at MIT. Fluorescence-positive cells were sorted into PLO/Laminin-coated 96-well 
plates. The cell lines without CRISPR/Cas9 gene editing were used as negative controls 
for FACS. Sorted cells were grown in recovery buffer (2i, supplemented with 2-5% FBS) 
for 6 hours before the buffer was replaced by regular 2i media. 
 
Stable Expression of NLS-MCP-SNAP in ES cell lines 
In order to visualize MS2 stem loops engineered into endogenous transcripts, we 
generated cells stably expressing the MS2 capsid protein (MCP) fused to a SNAP-Tag 
moiety by incubating cells with a newly cloned EF1α-NLS-MCP-SNAP expression 
vector. The SNAP sequence was amplified from pENTR4-SNAPf (Addgene plasmid 
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#29652) using primers listed in Table S5, then digested with AarI. The vector was 
generated by digesting phage-Ubc-NLS-2xMCP-Halo (Addgene plasmid #64540) with 
NotI and XbaI to remove Halo and replace it with the SNAP DNA sequence. The 
2xMCP-SNAP sequence was then digested with NotI and BsrGI and inserted into the 
backbone of pDendra2-C (Clontech) with an AarI placeholder for cloning a new 
promoter. The AarI placeholder was generated by annealing two oligonucleotides to form 
PciI and NotI overhangs (Table S5). The human elongation factor 1 alpha promoter 
(EF1α) was chosen for improved stability in mESC. By digesting pDendra2-C with PciI 
and BsrGI, we removed the CMV promoter and Dendra2 in order to replace these with 
EF1α and 2xMCP-SNAP. When digested with AarI, the placeholder exposes sticky ends 
compatible with insertion of an EF1α promoter sequence, which was obtained from 
pHAGE-EFS-MCP-3XBFPnls (Addgene #75384) through double-digestion with NheI 
and MluI. Intermediate and final ligation products were transformed into Subcloning 
Efficiency DH5α Competent Cells (Life Technologies) and confirmed by Sanger 
Sequencing before transfection. The plasmids used for cloning EF1α-NLS-MCP-SNAP 
are listed in Table S6.  
   EF1α-NLS-MCP-SNAP was then transfected into the Dendra2-Rpb1/Halo-Med19 
cell line using 4D Nucleofector X Unit (Lonza) with P3 Primary Cell Nucleofection Kit 
(Lonza). 3 days after transfection, cells were incubated with 100 nM JF646-SNAPtag 
ligand for 20 min and washed three times. Single cells with positive signals were sorted 
into 96-well plates by FACS. Two weeks after FACS, sorted single cells were incubated 
with 100 nM JF646-SNAPtag ligands again to be tested on the microscope stage. Under 
642-nm illumination, only cells with stable fluorescence signals from JF646 in the 
nucleus were selected to grow a Dendra2-Rpb1/Halo-Med19/MCP-SNAP cell line. 
 
Generating Esrrb-T2A-PuroR-24xMS2 Cell Line  
Starting with the previously engineered Dendra2-Rpb1/Halo-Med19/MCP-SNAP 
cell line, a repetitive DNA region encoding 24 MS2 stem loop repeats (24xMS2) was 
knocked into the 3´ untranslated region (UTR) of the endogenous mouse Estrogen-related 
receptor beta gene (Esrrb) using a CRISPR sgRNA that cleaves immediately before the 
TGA stop codon of endogenous Esrrb in exon 7 (ENSMUSG00000021255). The guide 
sequence (Table S1) was inserted into pSpCas9 (BB)-2A-Puro(PX459)V2.0 as described 
above. The sgRNA-Cas9 plasmid was co-transfected with a circular repair plasmid 
containing homology arms of 800 base-pairs on either side of the Esrrb stop codon. For 
selection of cells edited to express the 24xMS2 sequence we inserted a T2A-PuroR-
24xMS2 cassette between the homology arms.  
   The repair plasmid was derived from a minimal mammalian expression vector 
(GeneArt® Gene Synthesis, Life Technologies, Carlsbad, CA) that served as the initial 
destination vector for the Esrrb repair template. The backbone was linearized by PCR, 
using long primers with AarI sites for insertion of a synthetic gene block (AarI-gblock-
v2) in order to introduce multiple cloning sites into the initial destination vector. The 
primers used for backbone amplification and the full AarI-gblock-v2 sequence are listed 
in Table S5. Two inverted AarI sites flanked by Esrrb LHA and RHA were synthesized 
as a single gene block (Genewiz FragmenGENE Synthesis), which was cloned into the 
initial destination vector using restriction enzymes MfeI and MluI to create an 
intermediate destination vector. A donor plasmid encoding self-cleaving peptide T2A and 
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a Puromycin-resistance gene (PuroR) was created separately by PCR amplification of 
PuroR from pCRISPaint-HaloTag-PuroR (Addgene plasmid # 80960), with primers 
encoding the T2A sequence (Table S5), as well as EagI and BamHI restriction sites for 
insertion into pDZ415 (24MS2SL loxP-Kan-loxP) (Addgene plasmid # 45162). The 
resulting donor plasmid containing T2A-PuroR-24xMS2 was digested with EagI and SalI 
to produce restriction overhangs compatible with AarI digestion and T7 ligation into the 
Esrrb destination vector. The final Esrrb-MS2 HDR plasmid was transformed into Stbl3 
competent cells and verified by Sanger Sequencing prior to transfection. The plasmids 
used for cloning the Esrrb-MS2 HDR plasmid are listed in Table S6. 
 
PCR genotyping  
Sorted cells were cultured as distinct monoclonal cell lines. Genomic DNA from 
each cell line was isolated using GeneElute™ Mammalian Genomic DNA Miniprep Kits 
from Sigma-Aldrich (St. Louis, MO). To test the cells for Dendra2 and HaloTag 
insertion, PCR primers were designed to amplify the targeted gene loci as well as the 5’- 
and 3’-junctions between the desired insert and left or right homology arms (j5 and j3 
respectively as in Table S7, Table S8, and Table S9). To check the 3’UTR of Esrrb for 
successful knock-in of the T2A-PuroR-24xMS2 transgene, PCR junctions j5 and j3 were 
designed to amplify the junctions between homology arms and the transgenic cassette, 
while avoiding the repetitive array of MS2 stem loops. PCR products were analyzed on 
1% agarose gels (Fig. S2 and S15). Gel fragments were extracted using Monarch® 
Nucleic Acid Purification Kits (NEB) before submission to Genewiz for Sanger 
Sequencing. Alignment of the DNA sequences confirmed integration of Dendra2 or 
HaloTag in Med19 and Rpb1, respectively, in Halo-Rpb1/Dendra2-Med19 and Dendra2-
Rpb1/HaloTag-Med19 cell lines. Sequencing results are summarized in Fig. S2 and S15 
and Tables S10.  
  
Differentiation to epiblast-like cells (EpiLC) 
Prior to EpiLC differentiation induction, mESC were cultured in 2i media at least for 
two passages from frozen stocks. After washing with PBS and sieving with a 70m cell 
strainer (Corning Falcon), mESC were transferred to either 6-well plates for qRT-PCR or 
glass-bottom dishes for fluorescence imaging, in N2B27-based medium supplemented 
with 1% KOSR (Invitrogen) and 12 mg/ml bFGF (Peprotech). Dishes and plates were 
coated with 5 μg/mL Fibronectin (16). 
 
JQ1, DRB, hexanediol treatment 
Cells were plated on glass-bottom dishes and maintained in 2i media until a 
confluency of >50% was reached. For JQ1 treatment, 500 nM-5 μM JQ1 (Sigma-Aldrich, 
SML0974) were added to 2i media and maintained for 24 hours before imaging.  
   For DRB (5,6-Dichloro-1-beta-D-ribofuranosyl-benzimidazole) treatment, 100-
200μM DRB (Sigma-Aldrich, D1916) was added to L-15 medium (32). For DRB 
washing experiments, DRB buffer was exchanged with L-15 medium after gently 
washing the dishes three times with 37°C 1x PBS or L-15 medium.  
   For hexanediol treatment cells were imaged in 500µl L-15 medium. We prepared a 
stock solution of 20% (v/v) hexanediol in L-15 and carefully added 500µl of pre-warmed 
solution to the imaging dish on the microscope for a final concentration of 10% (v/v). 
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Stacks (z-range 5m, z-spacing 400nm) of the same field of view were acquired every 
before addition of hexanediol, and 1, 3, 5, 7, 9, 12, and 15 min after addition. Clusters 
were identified in maximum intensity projections of the stacks. 
 
Super-resolution imaging 
Live cell PALM imaging was carried out as described before (14, 15, 33). Briefly, 
cells were simultaneously illuminated with 1.3 W/cm2 near UV light (405nm) for photo-
conversion of Dendra2 and 3.2 kW/cm2 (561nm) for fluorescence detection with an 
exposure time of 50 ms. We acquired images of Dendra2-Mediator for 100s (2000 
frames) and Dendra2-Pol II for 150s (3000 frames) for quantification of transient and 
stable clusters. For dual color imaging, cells were incubated with 100nM JF646 Halo 
ligand for 20 min and washed with 1x PBS, followed by 30 min incubation in 2i media 
without JF646-HaloTaq ligands, to wash out unbound HaloTaq ligands before 
fluorescence imaging in L-15 medium. We acquired 100  frames (5s) with 642nm 
excitation and quickly switched to simultaneous 405/561 imaging for PALM. Super-
resolution images were reconstructed using MTT (34) and qSR (35). 
 
Density based spatial clustering of applications with noise (DBSCAN) analysis 
We use a clustering algorithm, density based spatial clustering of applications with 
noise (DBSCAN) (36), to define the area of clustered regions in super-resolution data. 
Based on the single molecule localization in a super-resolution image, DBSCAN tests if a 
localization can be grouped with nearby localizations. Once a localization has a minimum 
number of nearby localizations (N) within a specific distance (R), it is grouped with other 
localizations also satisfying N and R criteria in their local neighborhood. We defined the 
parameters as N = 15-20 (points) and R = 100 (nm) for Dendra2-Mediator clustering, and 
N = 25-30 (points) and R = 90-95 (nm) for Dendra2-Pol II clustering. Varying the 
parameters for an image, we chose a set of parameters (N, R) for which the DBSCAN-
clustering result is agrees with intensified regions in the super-resolution image generated 
from our qSR software module (Fig. S4). For DBSCAN analysis, we used the 
‘DBSCAN’ module embedded in qSR software. 
 
Fluorescence Recovery After Photobleaching (FRAP) 
FRAP experiments were performed at the W.M. Keck Microscopy Facility at the 
Whitehead Institute using an Andor Revolution Spinning Disk Confocal microscope with 
FRAPPA module. Cells were labelled with JF646 Halo ligand as described above. 
Images of a single confocal plane were taken with an exposure time of 200 ms. The 
bleach spot was centered on a cluster and images were taken with 1s interval for 1min to 
measure the fluorescence recovery in the cluster. To quantify FRAP recovery we 
followed the approach described by Darzacq et al. (37). Briefly, we determined the 
integrated intensity of the cluster as a function of time, subtracted background intensity 
from a neighboring region of equal size, corrected for overall photo-bleaching based on a 
reference region within the same cell, and normalized to pre-bleach intensity. We 
averaged normalized traces and fitted the recovery with a single exponential recovery 
model , where A denotes the recovery fraction and  is the 
mean recovery time. 
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Lattice Light Sheet Microscopy 
We built a lattice light sheet microscope under license from HHMI, Janelia Research 
Campus as described in (10). Cells were grown and labeled as described above, and 
imaged in Leibovitz’s L-15 medium at 37°C for up to 3 hours. A lattice light sheet 
consisting of 61 Bessel beams was generated with an annulus of inner/outer numerical 
aperture NA 0.44/0.55. Fast tracking experiments were conducted with 25ms frame 
interval in a single plane and 1.2 mW laser power (642nm) measured before the 
excitation objective. Time-lapse imaging was conducted with 100ms exposure time and 
laser powers of 0.1 mW (488nm) and 0.6 mW (642nm) respectively. Cells were stepped 
through the light sheet to acquire stacks with 0.3m z-spacing, resulting in a rate of 10-
30s/stack. Fluorescence was detected using a quad band notch filter in front of a sCMOS 
camera (Orca Flash v4.2, Hamamatsu). Images were processed (deskewed) using LLSpy 
(38) and FIJI (39). Where appropriate we performed chromatic aberration correction by 
translating one of the color channels based on multi-color bead (TetraSpeck, Thermo 
Fisher Scientific) images. Analysis was performed using MATLAB and FIJI scripts. 
 
Counting clusters using lattice light sheet microscopy 
The number of clusters per cell was determined from maximum intensity projections 
of full volumetric data. To facilitate detection of dim spots we subtracted a median 
filtered image (radius 8 pixel) from the raw data, smoothed with a 1 pixel radius Gaussian 
kernel and applied a threshold to count the number of local maxima above background 
within a cell nucleus. Nuclear outlines were segmented manually. Counting was 
performed using the brighter Halo-tagged cell lines for both, Pol II and Mediator, in 
separate experiments (see Fig. S6).  
 
Colocalization analysis 
For lattice light sheet-based colocalization analysis cells were labelled with JF646-
Halo-ligand as described above and fixed in 4% PFA. Stacks were acquired using 488nm 
illumination for direct visualization of Dendra2-labelled protein and 642nm illumination 
for Halo-tagged protein. We then identified clusters as described above and fitted their 
centroid position with a 2D Gaussian peak. To quantify colocalization of diffraction-sized 
signals we opted for an object-based approach. Since Dendra2 signal was weaker and 
dimmer clusters may not be detectable above the noise floor, we analyzed colocalization 
based on clusters identified in the Dendra2 channel. For each clusters in this channel we 
measured the distance to the nearest identified cluster in the Halo channel. Since lattice 
light sheet microscopy is a diffraction-limited imaging modality with a resolution of 
approximately half the emission wavelength (detection objective NA 1.2), we define 
those cluster as colocalized that were separated by less than 300nm. 
   We note that colocalization between PALM super-resolution images and 
epifluorescence images is not well-defined since both channels have different resolution 
and pixel sizes. Moreover, the PALM images are merely renderings of single molecule 
localization data. Here, we generated a rendered super-resolution image by placing 
Gaussian peaks with spread corresponding to the localization accuracy (50 nm) at the 
position of single molecule localizations. To localize JF646-Halo-cluster regions in 
conventional fluorescence images, we subtracted background (rolling ball with 50 pixel 
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radius) and adjusted the contrast to remove fluorescence background in the nucleus which 
is higher than background in the cytoplasm. We adjusted the size of direct images to that 
of super-resolution images and merged color channels in ImageJ. We then identified 
clusters in PALM images. These corresponded to the brightest peaks in the epi 
fluorescence images. Since clusters in PALM images are not well-described by a single 
Gaussian peak we calculated the centroid (center of mass) of a region of interest (800nm 
x 800nm) and determined the distance between the centroids of the PALM and epi 
fluorescence channels (Fig. S9). 
 
Tracking clusters 
Clusters were localized in maximum intensity projections using ThunderStorm (39) 
and connected to trajectories using a MATLAB script. The mean square displacement 
was calculated for all trajectories spanning at least 60 frames. (Fgf5 enhancer using 
CARGO: 23 trajectories comprising 7009 displacements in 15 cells. Clusters: 18 
trajectories comprising 5452 displacements in 6 cells.). We fitted with a general model 
 in Origin to determine the scaling exponent of the mean square 
displacement,  (Fig. S13).  
 
Nascent RNA pulse labelling 
Nascent RNA was labelled using the Click-IT RNA Alexa Fluor Imaging Kit 
(Thermo Fisher Scientific) with a modified protocol. For pulse labelling we incubated 
cells with 100nM JF505 Halo-ligand and 100µM DRB in 2i medium for 20mins followed 
by 10mins in 100µM DRB in 2i medium without JF505 Halo-ligand. We then exchanged 
the medium to 2i supplemented with 2.5mM 5-ethynyl uridine (EU) for 2mins and fixed 
immediately in 4% PFA. For control experiments medium was exchanged to 2i with 
2.5mM EU and 100µM DRB in the last step to maintain transcription inhibition. Click-
labelling of EU incorporated into nascent RNA  (40) was performed according to 
manufacturer instructions using AlexaFluor647 azide (Thermo Fisher Scientific).  
Fixed cells were imaged on the lattice light sheet microscope. Clusters were 
identified in the Mediator-JF505 channel as described below. For analysis we subtracted 
background in both channels by median-filtering (radius 8 pxl). We extracted regions of 
interest centered on the cluster signal from single z planes in both, the Mediator-JF505 
and the EU-AF647 channel. To further enhance visibility we averaged the signal for all 
regions of interest in individual cells. As a control, we randomized the cluster positions 
within the nucleus and performed the same type of analysis. We note that nucleoli 
typically show the strongest EU signal because they contain highly transcribed rDNA 
genes and DRB does not act on Pol I. Nucleolar regions were thus excluded from the 
analysis. 
 
Fluorescent in situ hybridization (FISH) 
We designed RNA FISH probes (Stellaris FISH Probes, LGC Biosearch 
Technologies, Novato, CA), targeting intron 3 of Esrrb. Probes were labeled with 
Quasar670. Cells were grown on 5mm round cover glasses as described above. Cells 
were labelled with JF549-Halo ligand as described above, washed with  37°C 1x PBS,  
fixed with 4% paraformaldehyde in PBS for 10 min, washed with 1x PBS three times, 
and permeablized in 70% ethanol for 1h at 4°C. For probe hybridization, we followed the 
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Stellaris protocol for adherent cells incubating with 125nM probe concentration for 3-
4hrs. All samples were imaged using Lattice Light Sheet Microscopy on the day of 
preparation and under identical imaging conditions. 
 
 
Tracking of endogenous transcription sites and clusters 
For dual-color imaging of MS2-labelled gene loci and clusters we incubated cells 
with a mix of 100nM JF646-SNAP-ligand and JF549-Halo-ligand. Stacks were acquired 
with 1min interval and 100ms exposure time using laser powers of 0.05 mW (561nm) 
and 0.3 mW (642nm). The Esrrb transcription site was readily identified as a diffraction-
limited fluorescent peak in maximum intensity projections. For further analysis we 
subtracted background plane-by-plane by median-filtering (8 pxl radius). The 
transcription site was tracked in maximum intensity projections using the 
ThunderSTORM ImageJ plugin (41), and in each frame the distance to the nearest cluster 
was determined. 
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Supplementary Figures 
 
 
 
Fig. S1. CRISPR/Cas9 gene engineering for dual-color imaging 
 
To endogenously label RNA Polymerase II (Pol II), we picked the largest subunit, Rpb1, 
as described before for mouse embryonic fibroblast cells (33). To label Mediator we chose 
Med19 subunit, which is the largest subunit that forms the main frame of the Middle 
domain in the Mediator complex (42). To prevent functional interruption, we targeted the 
N-terminal domain of Med19 (42, 43). Fluorescence-activated cell sorting (FACS) results 
of (A) wild type mESC, CRISPR/Cas9-engineered (B) Dendra2-Rpb1, (C) Dendra2-
Med19, (D) Halo-Med19 on the Dendra2-Rpb1 monoclonal cell line and (E) Halo-Rpb1 
on the Dendra2-Rpb1 monoclonal cell line. Vertical green lines indicate sorting threshold 
for Dendra2-positive signals with 488-nm excitation, and horizontal red lines indicate 
JF646-positive signals with 642-nm excitation. 
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Fig. S2. CRISPR validation by PCR  
(A) Genomic DNA was amplified by PCR from 3 cell lines using primers listed in Table 
S7 and S8. (B) Expected fragments were plotted with a legend that matches lane numbers 
to PCR products of interest. (C) Corresponding PCR products are represented in context 
under each gene locus: WT-Rpb1 (left), Halo-Rpb1 (middle), and Dendra2-Rpb1 (right) 
(D) WT-Med19 (left), Dendra2-Med19 (middle), Halo-Med19 (right). For each locus, PCR 
products were sequenced in both directions using the generative primers, and these traces 
were aligned with the full-length sequence to provide a consensus across each gene target.  
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Fig. S3. Mediator clusters in Dendra2-Med11 overexpressed mESCs 
 
Labeling of another Mediator subunit, Med11, with Dendra2 (42, 43). (A) Super-resolved 
image of over-expressed Dendra2-Med11 in live mESCs. Yellow arrows indicate Mediator 
clusters, and a blue box shows zoom-in image of one of the cluster (B) Corresponding 
tcPALM trace of the cluster highlighted in A showed a temporal detection profile of a 
stable cluster (C) Lifetime distribution of Dendra2-Med11 clusters (N=89 from 6 cells). 
Red bar indicates stable clusters (5.6%).  
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Fig. S4. DBSCAN analysis for cluster size measurement  
 
(A) A super-resolved image of Dendra2-Mediator mESC. (B) DBSCAN analysis result for 
the corresponding cell in A, with parameters of N = 15 (points) and R = (100 nm). Color 
code represents different clusters. (C) A super-resolved image of a region of interest 
(yellow box in A). (D) Corresponding DBSCAN analysis result for the region of interest. 
Grouped localizations by DBSCAN in D agreed with intensified regions of super-resolved 
image in C. (see Material and Methods) 
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Fig. S5. Box plots of Mediator and Pol II cluster size distribution 
 
Box plots of (A) Mediator and (B) Pol II cluster size showed that the area of clusters (red 
dots) as well as their number were reduced upon differentiation toward EpiLC. Clusters 
with stable signatures in tcPALM plots for highlighted in red (see Fig. 1C and 1F).  
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Fig. S6. Counting the number of clusters per cell nucleus 
 
Illustration of the procedure for counting the number of stable clusters per cell using Lattice 
Light Sheet Microscopy. (A) Dendra2-Pol II. (B) JF646-Pol II. (C) JF646-Mediator. Left 
to right for each panel: 1. Maximum intensity projection of 3D stack. 2. Median-filtered 
image. 3. Raw image after background subtraction. 4. Smoothed with Gaussian kernel (1 
pxl radius) for peak detection above background fluctuations (red crosses). 5. Segmented 
cell nuclei. Scale bar, 5μm. (D) The average number of clusters per nucleus in JF646-
Mediator was 14.5 ± 0.9 (n=88 cells). (E) For JF646-Pol II, we found 14.8 ± 0.8 clusters 
per nucleus (n=86 cells). These results are comparable with numbers obtained from super-
resolution imaging in a 2D focal plane covering 1/3 – 1/4 of the nuclear volume (Fig. S8P 
and R).  
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Fig. S7. qRT-PCR and Chromatin Immunoprecipitation Sequencing (Chip-seq) for 
CRISPR-dual-labeled Dendra2-Rpb1/Halo-Med19 (DRHM) cell line upon 
differentiation 
 
Validation of stemness of the CRISPR-engineered mESC line and the EpiLC-
differentiation with qPCR and Chip-sequencing. (A) qRT-PCR results of Oct4, Sox2, 
Esrrb, Tbx3, Otx2 and Fgf5 expression levels for mESCs (blue bars) and 24-hour 
differentiated cells (orange bars). Expected gene expression variations for the 
differentiation – downregulation of Esrrb, Tbx3; upregulation of Otx2, Fgf5; while 
expression of Oct4, Sox2 maintained– are used as validation for EpiLC differentiation (17).  
(B-D) Chip-seq panels showing H3K27ac-, Rpb1- and Dendra2-Chip-seq binding profiles 
of wild-type (WT) mESC and CRISPR-dual-labeled Dendra2-Rpb1/Halo-Med19 (DRHM) 
cell line before and after EpiLC-differentiation. (B) Chip-seq profiles of H3K27ac and 
Rpb1 for Sox2 gene. (C) Chip-seq profiles of H3K27ac and RPB1 for Esrrb gene. (D) 
Chip-seq profiles of H3K27ac and Rpb1 for Otx2 gene. 
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Fig. S8. Mediator and Pol II clusters gradually disappear with differentiation.  
 
(A, B) Super-resolved images of Dendra2-Mediator and Dendra2-Pol II, under 
differentiation towards Epiblast-like cells (EpiLCs), at 0, 3, 6, 12, 18 and 24 hours after 
differentiation buffer exchange.  Rank-ordered cluster size distributions, at 0, 3, 6, 12, 18 
and 24 hours upon differentiation for (C-H) Mediator and (I-N) Pol II, respectively.  
Cumulative distribution function (CDF) plots of normalized cluster area distribution upon 
EpiLC-differentiation for (O) Mediator and (Q) Pol II, respectively. Cluster area is 
measured by DBSCAN Analysis (Fig. S4).  Time-curves of number of stable clusters per 
cell, upon differentiation for (P) Mediator and (R) Pol II, respectively.  N=21.8 ± 2.1(s.d.) 
cells and N=21.5 ± 4.5(s.d.) cells were analyzed at each differentiation time point (i.e. each 
for 0, 3, 12, 18 and 24h) for Mediator and Pol II, respectively. Scale bars represent 1 µm. 
All cells represented are live cells. 
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Fig. S9. Colocalization quantification  
 
(A-E) Quantification of colocalization from 2D images. (A and B) Direct images of cells 
expressing both JF646-Pol II and Dendra2-Mediator. (C) Live cell super-resolution image 
of Dendra2-Mediator overlaid with a thresholded image of JF646-Pol II. Right panels show 
zoom-in of colocalizing clusters  (yellow boxes). (D) Fixed cell super-resolution and epi 
fluorescence image overlay of clusters. (E) Box plot of distance distribution from super-
resolved centroid to epi fluorescence centroid in ROIs shown in C.  (F) Multicolor bead 
colocalization on the lattice light sheet microscope. Scatter plot for the distance between 
bead position in the 488nm channel and 642nm channel (n=47) and histograms along x and 
y axis. 
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Fig. S10. Dissolution of Mediator/Pol II clusters and western-blot for JQ1 treatment 
 
(A, Upper panels) Time-dependent epi-fluorescence images (488-nm excitation) of 
Dendra2-Mediator cells and (A, lower panels) time-dependent PALM super-resolution 
images for the corresponding cells after 1uM JQ1 treatment. (B, Upper panels) Time-
dependent epi-fluorescence images of Dendra2-Pol II cells and (B, lower panels) time-
dependent PALM super-resolution images for the corresponding cells after 1uM JQ1 
treatment. (C) Western-blot of Mediator subunit, Med1, for WT mESC and CRISPR-
labeled Dendra2-Med19 cell line. (D) Western-blot of RNA Polymerase II subunit, Rpb1, 
for WT mESC and CRISPR-labeled Dendra2-Med19 cell line. 
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Fig. S11. Statistics of cluster fusion events 
 
Intensity traces of clusters undergoing fusion events. Displayed are 5 fusion events for 
Mediator (left) and Pol II (right) each. Insets show clusters before (orange, blue) and after 
(black) the fusion event. Arrowheads mark clusters undergoing fusion. Bar graphs show 
average intensities of corresponding trajectories. Error bars represent standard deviation. 
With our current methods we estimated the frequency of fusion events to be about 1 event 
in 30-120min per cell. 
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Fig. S12. Mediator and Pol II clusters dissolve with hexanediol treatment 
 
(A and B) Dendra2-Mediator / JF646-Halo-Pol II images before and after 10% hexanediol 
treatment. (C and D) Dendra2-Pol II / JF646-Halo-Mediator images before and after 10% 
hexanediol treatment. Epi-fluorescence images (left panels). 
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Fig. S13. Mobility of chromatin loci and clusters 
 
Mean square displacement (MSD) of the dCas9-GFP labelled Fgf5 enhancer locus (23) 
and Pol II-JF646 clusters. On short timescales <300ms both showed an exponent  
indicative of confined diffusion. The smaller offset of the Pol II cluster MSD as compared 
to the Fgf5 enhancer locus resulted from a better signal to noise ratio. 
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Fig. S14. Nascent RNA pulse labelling 
 
(A) Maximum intensity projection of a fixed JF646-Mediator cell imaged using lattice light 
sheet microscopy. Arrowheads indicate clusters. (B) Single plane from a 3D stack after 
background subtraction showing three clusters. (C) Nascent RNA was labelled in the same 
cell using an ethynyl uridine (EU) run on assay and Click-labelling. EU was incubated for 
2min before fixation. Boxes highlight the positions of clusters identified in (B). (D) 
Overlay of the signal revealed that accumulations of nascent RNA occured at cluster 
positions.  (E) Signal from single planes centered on the JF646-Mediator clusters. RNA 
accumulation was detected at all clusters. (F) Averaged signal for all clusters in individual 
cells with number of clusters identified in each cell indicated. In all cases, we found 
accumulation of nascent RNA at clusters. (G) As a control for the observed RNA 
accumulation we randomly picked sites within the nucleus instead of the cluster positions 
and performed the same analysis. Only a diffuse signal was visible in the RNA channel. 
(H) When EU was incubated before DRB washout we also found only diffuse RNA signal. 
Scale bars 2µm (A-D), 1µm (F-G). 
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Fig. S15. MS2-insertion validation by PCR  
(A) Genomic DNA was amplified by PCR from wild-type and Esrrb-T2A-PuroR-24xMS2 
cell lines using primers listed in Table S9. (B) Expected fragments are plotted with a legend 
that matches lane numbers to PCR products of interest. (C) The PCR products for Esrrb 
sequencing are represented in context under the wild-type and modified gene locus WT-
Esrrb (left), Esrrb-T2A-PuroR-24xMS2 (right). A partial sequence of the modified allele 
is reported in Table S10. 
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Fig. S16. Dual-color FISH for Esrrb and the MS2 sequence. 
We performed dual-color FISH in fixed cells to confirm insertion of the 24xMS2 cassette 
in the Esrrb locus. Images were acquired using epi-fluorescence microscopy. Foci detected 
in the MS2 FISH channel colocalized with Esrrb loci. Note that only one allele of Esrrb 
contained the MS2 insertion, but both alleles were expressed as indicated by the two Esrrb 
loci detected per cell. 
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Fig. S17. Quantification of colocalization between Esrrb gene locus and clusters. 
(A) Quantification of colocalization between the Esrrb locus and Mediator-JF549 by 
measuring the distance from Esrrb transcription sites identified by intronic FISH (intron 3) 
to the nearest cluster using lattice light sheet microscopy. Across 125 transcription sites 
identified in 82 cells we found a cluster to colocalize (<300nm, 2D distance) with 22% of 
the loci. We note that 93% of the loci had a cluster within a distance of 1m. (B) 
Representative image (single plane) showing Esrrb locus (magenta) and Mediator-JF549 
clusters. 
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Fig. S18. Full image sequence of Esrrb-MS2 interaction with a cluster 
Panels show a single plane from a 3D stack after background subtraction centered on the 
Esrrb locus. Magenta: Esrrb-MCP-JF646 signal. Green: Mediator-JF549 signal. Compare 
Movie S3. 
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Table S1. Oligo sequences for cloning sgRNAs  
 
sgRNA  5'-3' Oligonucleotide Sequence  
Med19_sgRNA #1  
(forward) CACCGAAGTAATTAACGCCCGATCC       
(reverse) AAACGGATCGGGCGTTAATTACTTC  
Med19_sgRNA #2  
(forward) CACCGAGTAATTAACGCCCGATCCC  
(reverse) AAACGGGATCGGGCGTTAATTACTC  
Med19_sgRNA #3  
(forward) CACCGACGCCCGATCCCGGGTAACC  
(reverse) AAACGGTTACCCGGGATCGGGCGTC  
RPB1_sgRNA # 1  
(forward) CACCGCTCTCTTGATGGTGCGCAGC  
(reverse) AAACGCTGCGCACCATCAAGAGAGC  
RPB1_sgRNA # 2  
(forward) CACCGAGTCCTGAGTCCGGATGAAT  
(reverse) AAACATTCATCCGGACTCAGGACTC  
RPB1_sgRNA # 3  
(forward) CACCGCGGGCATGCGCTGTCCCCGG  
(reverse) AAACCCGGGGACAGCGCATGCCCGC  
ESRRB_sgRNA  
(forward) CACCGTGCTGGAGGCCAAGGTGTGA 
(reverse) AAACTCACACCTTGGCCTCCAGCA 
* Red : overhang sequences for BbsI cloning  
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Table S2. PCR primers for repair template amplification  
   
Full Primer Name  5'-3' Sequence  
Med19_R-T_short Fwd CCAGACCCGGATGTAGATCTCTTATTGG  
Med19_R-T_short Rev CCGCATCAGGTAGAAGGGGC  
RPB1_R-T_short Fwd CAGCCAGTTCTCTCCTCAGAAGCG  
RPB1_R-T_short Rev CAACCCTGTCTCGTTGAACCGCAGC  
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Table S3. Gibson Assembly primers for Halo-Med19 
 
   Full Primer Name  5'-3' Sequence  
Med19-Gibson-40_F CGACGCTCGAGATTTCCGGCATGGAGAACTTCACGGCACT  
Med19-Gibson-40_R CCAGTACCGATTTCTGCCATAGCACTCTGCGCTGC      
Halo-Gibson-40_F AACCAGCAGCGCAGAGTGCTATGGCAGAAATCGGTACTGGC  
Halo-Gibson-40_R AGTGCCGTGAAGTTCTCCATGCCGGAAATCTCGAGCGT  
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Table S4. AarI cloning primers for Halo-Rpb1 
 
Full Primer Name 5'-3' Sequence 
RPB1 Halo AarI F TCACCTGCTTTTATGCACGGGGGTGG 
RPB1 Halo AarI R TCACCTGCTTTTCCATGGCGAGGCAGGCG 
Halo-RPB1 AarI F TCACCTGCAAAAATGGCAGAAATCGGTACTGG 
Halo-RPB1 AarI R TCACCTGCTTTTGCATGCCGGAAATCTCGAGCG 
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Table S5. Custom fragments for EF1α-NLS-MCP-SNAP and Esrrb HDR plasmid 
cloning 
 
Fragment Name 5'-3' sequence 
AarI-gblock-v2 AAAcacctgcAAAATCAGaagtataggaacttcGgatcCGCTACTAACTTCAGCCTGCT
GAAGCAGGCTGGCGACGTGGAGGAGAACCCTGGACCTAcgcgtggtcaccgagctcgaa
ttcgaagttcctatactcctatAAAAgcaggtgAAA 
AarI-gblock-adaptor F AAAcacctgcACCTctataagaataggaacttcggaataggaacttcCCCAGCTGAgat
ATCCGACATGTTGTTAACCCAGCCTGGGGTGCCTAATGAG 
AarI-gblock-adaptor R TTTcacctgcTTTTctgatagaataggaacttcggaataggaacttcTTgataTCGGCA
GCTGTTAACCaattgTTTGCCTTCCGCCAATTCGC 
T2A-PuroR-EagI_F CCTcggccgTCCGGAGGAGAGGGCAG 
T2A-PuroR-BamHI_R ACTggatccTCACGCTCCAGGCTTCCT 
SNAP-AarI-XbaI F AAcacctgcAAAACTAGaatggacaaagactgcgaaatgaagc 
SNAP-AarI-BsrGI R AAcacctgcAAAAGTACAAacccagcccaggcttg 
AarI-placeholder-oligo-F CATGCTAGTTTTGCAGGTGAAAAGGGGTTTTCACCTGCAAAAcgcg 
AarI-placeholder-oligo R ggcccgcgTTTTGCAGGTGAAAACCCCTTTTCACCTGCAAAActag 
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Table S6. Plasmid Sources for EF1α-NLS-MCP-SNAP and Esrrb HDR plasmid 
cloning 
 
Plasmid Name source 
16AANK7P_1841307_Actb Geneart 
pDZ415 (24MS2SL loxP-Kan-loxP)  gift from Robert Singer & Daniel Zenklusen (Addgene 
plasmid # 45162) 
pCRISPaint-HaloTag-PuroR  gift from Veit Hornung (Addgene plasmid # 80960) 
pDendra2-C Clontech 
phage ubc nls ha 2xmcp HALO gift from Jeffrey Chao (Addgene plasmid # 64540) 
pHAGE-EFS-MCP-3XBFPnls  gift from Thoru Pederson (Addgene plasmid # 75384) 
pENTR4-SNAPf (w878-1) gift from Eric Campeau (Addgene plasmid # 75384) 
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Table S7. PCR primers for Rpb1 sequence validation 
 
Full Primer 
Name  
5'-3' Sequence  Primer 
Symbol  
Amplified Region  
mmRPB1-
seq F  
GAGCCCTAGCGTCAACAACT  Fout  WT-Rpb1:  Dendra2-
Rpb1:  
Halo-
Rpb1:  
1…1914  1…2604   1…2805  
mmRPB1-seq 
R  
CCTCTGGTATCAGCTCCCCT  Rout  (1914 bp)  (2604 bp)  (2805 bp) 
mmRPB1 
D2 j5 F  
GAGCCCTAGCGTCAACAACT  Fout    1…625  
(625 bp)  
  
mmRPB1 
D2 j5 R  
GTTCACGTTGCCCTCCATGT  RDendra2+72 
mmRPB1 
D2 j3 F  
ATTAACCTGATCAAGGAGGACAT  FDendra2+15  569…2536  
(1968 bp)  
mmRPB1 
D2 j3 R  
TATTTTGTGTCGGTCTGTGAGGT  Rout-2536  
mmRPB1 
HA j5 FWD 
TAGGGTTTCCTTGACCCCGA Fout-620   -620…584 
mmRPB1 
HA j5 REV 
CGAATGGAAAGCCAGTACCGA RHalo+31 (1204 bp) 
mmRPB1 
HA j3 FWD 
ATTATGTGGAAGTCCTGGGCGA FHalo+37 591…2103 
mmRPB1 
HA j3 REV 
CCCATGACACTTGTTTCCTCCA Rout-702 (1513 bp) 
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Table S8. PCR primers for Med19 sequence validation 
Full Primer 
Name  
5'-3' Sequence  Primer 
Symbol  
Amplified Region  
mmMed19-
seq F  
GACCATTGCAAATCGGTGGC  Fout  WT-
Med19:  
Dendra2-
Med19:  
Halo-
Med19:  
1…1051  1…1741   1…1942   
mmMed19-
seq R  
CCCGAGTTCTAAACAACGGC  Rout  (1051 
bp)  
(1741 bp)  (1942 bp)  
mmMed19-
D2-j5 F  
GACCATTGCAAATCGGTGGC  Fout    1…734       
(734 bp)  
  
mmMed19-
D2-j5 R  
GGATGTCGTAGCTGAAGGGC  RDendra2+184  
mmMed19-
D2-j3 F  
CCTGATCAAGGAGGACATGC  FDendra2+20  571…1741  
(1171 bp)  
mmMed19-
D2-j3 R  
CCCGAGTTCTAAACAACGGC  Rout  
mmMed19-
HA-j5 F  
GACCATTGCAAATCGGTGGC  Fout    1…864           
(864 bp)  
mmMed19-
HA-j5 R  
TGAATGACCAGGACGACCTC  RHalo+314  
mmMed19-
HA-j3 F  
ATTATGTGGAAGTCCTGGGCGA  FHalo+37  588…1942  
(1355 bp)  
mmMed19-
HA-j3 R  
CCCGAGTTCTAAACAACGGC  Rout  
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Table S9. PCR primers for Esrrb-T2A-PuroR sequence validation 
Full Primer Name  5'-3' Sequence  
Primer 
Symbol  
WT-
Esrrb:  
Esrrb-
MS2:  
mmEsrrb j5 F  CTGTAAGCATCCCAAGCCGA FEsrrb  1…1795   
(1795 bp)  
1…3809    
(3809 bp)   mmEsrrb j3 R  GCCCTTTAGAGCTCCTTCCTTT REsrrb  
mmEsrrb j5 F  CTGTAAGCATCCCAAGCCGA FEsrrb 
  
1…1031       
(1031 bp)  
T2A-PuroR-24xMS2 j5 R ACGTCGTCTCTTGTAGCCAAC 
RT2A-PuroRo-
24MS2 
T2A-PuroR-24xMS2 j3 F tgcaggtcgacaaggtcac 
FT2A-PuroRo-
24MS2  2708…3809  
(900 bp)  
mmEsrrb j3 R  GCCCTTTAGAGCTCCTTCCTTT REsrrb 
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Table S10. PCR-validated sequences  
 
Dendra2-Rpb1  
...CCGCGCGCGCTCCGTGTAGGCCGGTGCGGGCGGCCCCGTAGCGCAAGGGAGGGCGGGAAAGGAAGGGGCGGGACACAAGGGCGAAT
CTATAAAGGGCGTCACTCAGCCAGTTCTCTCCTCAGAAGCGCCGAGAGCGCGACCGGGACGGTTGGAGAAGAAGGTGGCTCCCGGAAGG
GGGAGAGACAAACTGCCGTAACCTCTGCCGTTCAGGATCCCGGTTACTTATTTATTCGTTACCCCTTTTcttcttcctccctcccaaaa
cctcctcctctcctcccttcttttgtttcctttttgGGAGCCGACGAATCTCCGGAAAGGGAGAAAAGGCTTTCTTTCAGCCCTTTTCG
TTCCTCTGCCTtcccccccccttcccccctcccccacctttccctcctccagcctttccctcccTATCCCGGGAGGTCTTTCCTGGTGG
CCGCCCGGACGGGTTCTGAGCACTTAGGCGGCGGTGGCGCAGGCTTTTTGTAGCGAGGTTTGCGCCTGCGCAGCGCGCCTGCCTCGCCA
TGAACACCCCGGGAATTAACCTGATCAAGGAGGACATGCGCGTGAAGGTGCACATGGAGGGCAACGTGAACGGCCACGCCTTCGTGATC
GAGGGCGAGGGCAAGGGCAAGCCCTACGAGGGCACCCAGACCGCCAACCTGACCGTGAAGGAGGGCGCCCCCCTGCCCTTCAGCTACGA
CATCCTGACCACCGCCGTGCACTACGGCAACCGGGTGTTCACCAAGTACCCCGAGGACATCCCCGACTACTTCAAGCAGAGCTTCCCCG
AGGGCTACAGCTGGGAGCGCACCATGACCTTCGAGGACAAGGGCATCTGCACCATCCGCAGCGACATCAGCCTGGAGGGCGACTGCTTC
TTCCAGAACGTGCGCTTCAAGGGCACCAACTTCCCCCCCAACGGCCCCGTGATGCAGAAGAAGACCCTGAAGTGGGAGCCCAGCACCGA
GAAGCTGCACGTGCGCGACGGCCTGCTGGTGGGCAACATCAACATGGCCCTGCTGCTGGAGGGCGGCGGCCACTACCTGTGCGACTTCA
AGACCACCTACAAGGCCAAGAAGGTGGTGCAGCTGCCCGACGCCCACTTCGTGGACCACCGCATCGAGATCCTGGGCAACGACAGCGAC
TACAACAAGGTGAAGCTGTACGAGCACGCCGTGGCCCGCTACAGCCCCCTGCCCAGCCAGGTGTGGATGCACGGGGGTGGCCCCCCCTC
CGGCGACAGCGCATGCCCGCTCCGCACCATCAAGAGAGTGCAGTTCGGAGTCCTGAGCCCGGATGAATTGGTAAGATAGTCCGCCCGTC
TCTCTGCTATGCCTTTGGCTGATGATCCTCTGGGAAGATGGGTCAGTGATGCTGATGTTGTGCGGGGGTCCAGCCTTCAAAAGTTAAAT
TATGCCAGGACTTAAACAAGCGAAATGCTATGCCTGAGATGAGTGCTTGACTGGACAGAGAAGAAAGATGTTTCCATACTTGAGCATTG
CTGCGGTTCAACGAGACAGGGTTGAAAGTTGTACAGGAAGTGGATCCCCAGTTTTAGTTCTTTCACCAATATTGAGCATCCTGCTATGT
GACAGTAATCAGACACTAGGAACACAGCTGCACAATAAATATAACAGAAACTCTACCTTCTAAAACACTATGGGAAAAACAGAGAAGAG
AGCTTAAGAACAAAAAGAAATGAGCAAAAATAAGTACCTAGATTAAAGCAAAATGAGGAAATGCTGTAAGAAGTCACTGAAATTGAATG
GTGTCAGGGTTTGGAAGACATACTTGCCAGGGATGGTGACATTCCCAAGTAATATCAGTCATCAGAGCTATTTTTTTAGGTGGAGGAAA
CAAGTGTCATGGGACTGAGAGGGAAATAAACTTGTATTCTAGAGACTGAAAAGCCAGTGTTGGGGCAGGCAGGGTTAGTGGGTGCGGAG
AGTGCACTGAAGAAGCACGGGATATTGTAAATTACGCT... 
Dendra2 start codon  RPB1 start codon   silent mutations  repair template 
 
HaloTag-Rpb1  
...GTGCGGGCGGCCCCGTAGCGCAAGGGAGGGCGGGAAAGGAAGGGGCGGGACACAAGGGCGAATCTATAAAGGGCGTCACTCAGCCA
GTTCTCTCCTCAGAAGCGCCGAGAGCGCGACCGGGACGGTTGGAGAAGAAGGTGGCTCCCGGAAGGGGGAGAGACAAACTGCCGTAACC
TCTGCCGTTCAGGATCCCGGTTACTTATTTATTCGTTACCCCTTTTCTTCTTCCTCCCTCCCAAAACCTCCTCCTCTCCTCCCTTCTTT
TGTTTCCTTTTTGGGAGCCGACGAATCTCCGGAAAGGGAGAAAAGGCTTTCTTTCAGCCCTTTTCGTTCCTCTGCCTTCCCCCCCCCTT
CCCCCCTCCCCCACCTTTCCCTCCTCCAGCCTTTCCCTCCCTATCCCGGGAGGTCTTTCCTGGTGGCCGCCCGGACGGGTTCTGAGCAC
TTAGGCGGCGGTGGCGCAGGCTTTTTGTAGCGAGGTTTGCGCCTGCGCAGCGCGCCTGCCTCGCCATGGCAGAAATCGGTACTGGCTTT
CCATTCGACCCCCATTATGTGGAAGTCCTGGGCGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATGGCACCCCTGTGCTGTTCCT
GCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCATGTTGCACCGACCCATCGCTGCATTGCTCCAGACCTGATCG
GTATGGGCAAATCCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGATGCCTTCATCGAAGCCCTGGGTCTG
GAAGAGGTCGTCCTGGTCATTCACGACTGGGGCTCCGCTCTGGGTTTCCACTGGGCCAAGCGCAATCCAGAGCGCGTCAAAGGTATTGC
ATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCCAGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACG
TCGGCCGCAAGCTGATCATCGATCAGAACGTTTTTATCGAGGGTACGCTGCCGATGGGTGTCGTCCGCCCGCTGACTGAAGTCGAGATG
GACCATTACCGCGAGCCGTTCCTGAATCCTGTTGACCGCGAGCCACTGTGGCGCTTCCCAAACGAGCTGCCAATCGCCGGTGAGCCAGC
GAACATCGTCGCGCTGGTCGAAGAATACATGGACTGGCTGCACCAGTCCCCTGTCCCGAAGCTGCTGTTCTGGGGCACCCCAGGCGTTC
TGATCCCACCGGCCGAAGCCGCTCGCCTGGCCAAAAGCCTGCCTAACTGCAAGGCTGTGGACATCGGCCCGGGTCTGAATCTGCTGCAA
GAAGACAACCCGGACCTGATCGGCAGCGAGATCGCGCGCTGGCTGTCGACGCTCGAGATTTCCGGCATGCACGGGGGTGGCCCCCCCTC
CGGCGACAGCGCATGCCCGCTCCGCACCATCAAGAGAGTGCAGTTCGGAGTCCTGAGCCCGGATGAATTGGTAAGATAGTCCGCCCGTC
TCTCTGCTATGCCTTTGGCTGATGATCCTCTGGGAAGATGGGTCAGTGATGCTGATGTTGTGCGGGGGTCCAGCCTTTCAAAAGTTAAA
TTATGCCAGGACTTAAACAAGCGAAATGCTATGCCTGAGATGAGTGCTTGACTGGACAGAGAAGAAAGATGTTTCCATACTTGAGCATT
GCTGCGGTTCAACGAGACAGGGTTGAAAGTTGTACAGGAAGTGGATCCCCAGTTTTAGTTCTTTCACCAATATTGAGCATCCTGCTATG
TGACAGTAATCAGACACTAGGAACACAGCTGCACAATAAATATAACAGAAACTCTACCTTCTAAAACACTATGGGAAAAACAGAGAAGA
GAGCTTAAGAACAAAAAGAAATGAGCAAAAATAAGTACCTAGATTAAAGCAAAATGAGGAAATGCTGTAAGAAGTCACTGAAATTGAAT
GGTGTCAGGGTTTGGAAGACATACTTGCCAGGGATGGTGACATTCCCAAGTAATATCA... 
 
Halo start codon  RPB1 start codon   silent mutations  repair template 
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Dendra2-Med19  
...ATCGGTGGCAGTTTCCTCACGAGGAGGAAAGCAATGGAAAGCAGAGCAGACAGAAGGCAATAAGGTCGGGCCAGCCATCGA 
GAAAGCCGCGGCACCGAGTACACCAAAGCAATCAGAGGCGCAAGGACAGCCATCTTTCCTGCCTACTCTCTCGCAGGCTCACTCCCGCTCCC 
CAAATCTTCGTCCTCCGCCCCCACCAGCAAGGCTTCTATTGGACCAAATATCAGATGCAACGCCTCCAGACCCGGATGTAGATCTCTTATTG 
GATGCTATAATAGATCAGAAAATGAATTAAATAGTCTATTGGTCCTCATCGTTGTCGCTTTTCTAACTGAGTCATTTTATTGGCTATTAGTC 
TGCGAACCACCTTCCTAACCAGTCTCTCAGGCGACGGAAGTAAGTTGCCGGAAGATGGTAGGCGGGGCTTAATGTATCCAATGATGGGACAC 
TCTTAGACGAAGAGGGTGGTACCCTGTGAAAGTACTGTCCAATCAAAGTAATTAACCCCGGATCCCGCGTAACCAGCAGCGCAGAGTGCTAT 
GAACACCCCGGGAATTAACCTGATCAAGGAGGACATGCGCGTGAAGGTGCACATGGAGGGCAACGTGAACGGCCACGCCTTCGTGATCGAGG 
GCGAGGGCAAGGGCAAGCCCTACGAGGGCACCCAGACCGCCAACCTGACCGTGAAGGAGGGCGCCCCCCTGCCCTTCAGCTACGACATCCTG 
ACCACCGCCGTGCACTACGGCAACCGGGTGTTCACCAAGTACCCCGAGGACATCCCCGACTACTTCAAGCAGAGCTTCCCCGAGGGCTACAG 
CTGGGAGCGCACCATGACCTTCGAGGACAAGGGCATCTGCACCATCCGCAGCGACATCAGCCTGGAGGGCGACTGCTTCTTCCAGAACGTGC 
GCTTCAAGGGCACCAACTTCCCCCCCAACGGCCCCGTGATGCAGAAGAAGACCCTGAAGTGGGAGCCCAGCACCGAGAAGCTGCACGTGCGC 
GACGGCCTGCTGGTGGGCAACATCAACATGGCCCTGCTGCTGGAGGGCGGCGGCCACTACCTGTGCGACTTCAAGACCACCTACAAGGCCAA 
GAAGGTGGTGCAGCTGCCCGACGCCCACTTCGTGGACCACCGCATCGAGATCCTGGGCAACGACAGCGACTACAACAAGGTGAAGCTGTACG 
AGCACGCCGTGGCCCGCTACAGCCCCCTGCCCAGCCAGGTGTGGATGGAGAACTTCACGGCACTGTTTGGAGCTCAGACTGACCCCCCACCG 
CCACCAAGCGCCCTAGGCTTTGGGCCTGGAAAGCCACCCCCGCCACCCCCTCCTCCTCCGGGAGGTGGTCCAGGCGCAGCCCCGCCCTCGAC 
GGCAACCTCGGCCCCCGCAGGAGCGGATAAGTCGACGGCTGGAAGTGGCCCCTTCTACCTGATGCGGGAATTGCCAGGTGAGTAGTAGGCCA 
AGAGTAGCCACTCAGATTGTAGTTCAGGTGAGGGTGTGGCTAGCCTGTCCCGCTAGGTGTGAGATAACAGGGCTACGCGGGGCCAGTGGGCA 
ACAGTGTCAGAAGCCCTTTGGCGATTCACAACCCTAAGGGATAACTTGATTTTCTGGGGTGGGTTTGGGTTGGGTGTGAATATCTGGGACAA 
CCTTCAGCGAGAAGTTCTGTGATCCGGGTTCTCTGACTGCCG... 
Dendra2 start codon  Med19 start codon   silent mutations  repair template  
  
HaloTag-Med19 
...ATCGGTGGCAGTTTCCTCACGAGGAGGAAAGCAATGGAAAGCAGAGCAGACAGAAGGCAATAAGGTCGGGCCAGCCATCGA 
GAAAGCCGCGGCACCGAGTACACCAAAGCAATCAGAGGCGCAAGGACAGCCATCTTTCCTGCCTACTCTCTCGCAGGCTCACTCCCGCTCCC 
CAAATCTTCGTCCTCCGCCCCCACCAGCAAGGCTTCTATTGGACCAAATATCAGATGCAACGCCTCCAGACCCGGATGTAGATCTCTTATTG 
GATGCTATAATAGATCAGAAAATGAATTAAATAGTCTATTGGTCCTCATCGTTGTCGCTTTTCTAACTGAGTCATTTTATTGGCTATTAGTC 
TGCGAACCACCTTCCTAACCAGTCTCTCAGGCGACGGAAGTAAGTTGCCGGAAGATGGTAGGCGGGGCTTAATGTATCCAATGATGGGACAC 
TCTTAGACGAAGAGGGTGGTACCCTGTGAAAGTACTGTCCAATCAAAGTAATTAACCCCGGATCCCGCGTAACCAGCAGCGCAGAGTGCTAT 
GGCAGAAATCGGTACTGGCTTTCCATTCGACCCCCATTATGTGGAAGTCCTGGGCGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATG 
GCACCCCTGTGCTGTTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCATGTTGCACCGACCCATCGCTGCATT 
GCTCCAGACCTGATCGGTATGGGCAAATCCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGATGCCTTCATCGA 
AGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTGGGGCTCCGCTCTGGGTTTCCACTGGGCCAAGCGCAATCCAGAGCGCGTCA 
AAGGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCCAGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACC 
ACCGACGTCGGCCGCAAGCTGATCATCGATCAGAACGTTTTTATCGAGGGTACGCTGCCGATGGGTGTCGTCCGCCCGCTGACTGAAGTCGA 
GATGGACCATTACCGCGAGCCGTTCCTGAATCCTGTTGACCGCGAGCCACTGTGGCGCTTCCCAAACGAGCTGCCAATCGCCGGTGAGCCAG 
CGAACATCGTCGCGCTGGTCGAAGAATACATGGACTGGCTGCACCAGTCCCCTGTCCCGAAGCTGCTGTTCTGGGGCACCCCAGGCGTTCTG 
ATCCCACCGGCCGAAGCCGCTCGCCTGGCCAAAAGCCTGCCTAACTGCAAGGCTGTGGACATCGGCCCGGGTCTGAATCTGCTGCAAGAAGA 
CAACCCGGACCTGATCGGCAGCGAGATCGCGCGCTGGCTGTCGACGCTCGAGATTTCCGGCATGGAGAACTTCACGGCACTGTTTGGAGCTC 
AGACTGACCCCCCACCGCCACCAAGCGCCCTAGGCTTTGGGCCTGGAAAGCCACCCCCGCCACCCCCTCCTCCTCCGGGAGGTGGTCCAGGC 
GCAGCCCCGCCCTCGACGGCAACCTCGGCCCCCGCAGGAGCGGATAAGTCGACGGCTGGAAGTGGCCCCTTCTACCTGATGCGGGAATTGCC 
AGGTGAGTAGTAGGCCAAGAGTAGCCACTCAGATTGTAGTTCAGGTGAGGGTGTGGCTAGCCTGTCCCGCTAGGTGTGAGATAACAGGGCTA 
CGCGGGGCCAGTGGGCAACAGTGTCAGAAGCCCTTTGGCGATTCACAACCCTAAGGGATAACTTGATTTTCTGGGGTGGGTTTGGGTTGGGT 
GTGAATATCTGGGACAACCTTCAGCGAGAAGTTCTGTGATCCGGG... 
Halo start codon  Med19 start codon   silent mutations  repair template  
 
 
39 
 
 
Esrrb-T2A-PuroR-24xMS2 
...ATATCCCCGCCGGCTCCCTCTATCAGCACACCCTCCCCTCGCCCCCAAACACCTAGACATTGACTTCCATCCCTTTATATCTGTTCTGAG
TTGTAAGGTTGGTGGCTGTACTGCATGTGAGTGGTACCCATGGCCCAGCATCATCATGAAGACGTGATGATGTCAGGGTTAGGTGATAGC
CGTGAGGTTCCTAAGACCCAGGTGCTTAATTGTTGCTGTATAACTGTATGAGGTAGGTATGGCTAGGAAAATGGGGGACAGAGAAGTTA
TATAATGTCTCACATAACCCAAAAGGGACTGCCAGCCAGATTCCAGAGTCCCCCGAACGCCTCTGAGACATCCAATAGGTCTGCCCATGTT
CATCGGCAGTGCCCTCCTGGTGGTCTCTCTATGAGGTCTGAGCTCAGTTCTACCCTCCTCAGTCTCTGACTCAGCCCTGCATCAAAGATCCT
CATTCTACTCTGAATAGTCAGTCAGCAGACAGACAGACAGAGACAGGCTGGCTGCTGGTCTGTCCTCCACTCCAGAAATGCCTTCCGTGTT
GGGGGGTGGCAGCCAGCCCCTGCTGACACTGCCCCTCTCCTGTGTCCACAGATTCGATGTACATTGAGAACCTGGAGGCGGTGCAGAAG
CTCCAGGACCTGCTGCACGAGGCGCTGCAGGACTATGAGCTGAGTCAGCGCCACGAGGAGCCGCGGAGGGCCGGCAAGCTGCTGCTGA
CGCTGCCCCTGCTGAGGCAGACAGCCGCCAAAGCCGTGCAACACTTCTACAGCGTGAAACTGCAGGGCAAGGTGCCCATGCACAAACTCT
TCCTGGAGATGCTGGAGGCCAAGGTGtggccgTCCGGAGGAGAGGGCAGAGGAAGTCTGCTAACATGCGGTGACGTCGAGGAGAATCC
TGGCCCAATGACTGAATACAAGCCTACTG…24xMS2…caaggtcaccTGATGGCCCAGCACATGGACGGACGGACACGATCCAAGTGGAGA
CCTCCACAGCCACCAGCCTCGACTTTTTTCACACCCGCATCGGGGCTCTGAGCTGTCCCAGAAGAAGGGGTCTTCTTGCTTCCTGGCCATGT
GCAGACTCCTGGGGACAGCAGATGGGGAGGTGGGGATGGGGAGGGTAGGGGCGGGGGGCTCATCTGTCACCCGCATTTTCTTTGGAAT
TTTTTTTTTCCTTCTCCATGGGCAGTGCTAAGGCTTGGGCCAGGGACGACTTCCCTTAGAGCTGGAGACCACCAGAGGAAGCAGCCTTCCT
GCAAGGGATCCATTTCTGGACCTCTCCCTATTTAGGACCTGGAGGTATCTGGATGGGCAGTGCTTAGTGCCCGGGACCCAAGAGACATAG
ATTGGGGGCTCCTGAAGGTGTTGGTGTCACGGTGGGCAGTCCCTTGGGGCAGAACGTCTCTGTGGCCTATCCCGAGGCTCTGTTCCTCCT
CCATCTAGCTGGCTCCCTCCACTTTCCCCTTTCTTATTGTCCCAGTACACCCAGTTCTCAGTGGATGCTCCTGCTAGAGTAGCCACATCCCCA
CCCCGAAGAACCCCTCCCCTGCTTCCTGCCCCTACCTCAGCCAGCCGGAACTCACTGGCTCAGAAAAGAGTTGGGTTCTGTACCCACTGCT
CTTTTTGCCTGCTGTTTCTCCTTCTCCTCTTGGGCATGGCCAGTCTAGAAACCTATGGAGAATTCAGGACCTGGCCCCACCAGAGGTCACTT
GAGGGACTCTCAAGGTCAGTAGCTTAGGTTGGGGTGTAGGATAGCAGAGAG... 
T2A    PuroR (partial sequence)  repetitive region (not sequenced)  repair template 
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Movie S1. Pol II clusters coalescing 
Typical example of Pol II clusters coalescing as discussed in Fig. 3. Maximum intensity 
projection of full cell nucleus, no background subtracted. Time is indicated in upper right 
corner. Scale bar 5µm. 
 
 
Movie S2. Mediator clusters coalescing 
Typical example of Mediator clusters coalescing. Maximum intensity projection of full 
cell nucleus, no background subtracted. Time is indicated in upper right corner. Scale bar 
1µm. Two consecutive coalescence events were observed for JF646-Mediator. 
 
 
 
Movie S3. Esrrb locus and Mediator cluster 3D tracking 
3D rendering of dual color lattice light sheet data showing an Esrrb gene locus labelled 
by MS2-tagged nascent mRNA dynamically interacting with a Mediator cluster. Scale 
bar 1 µm. 
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